EMERGENT BIOSOLUTIONS INC (EBS)

US29089Q1058 - Common Stock

8.3  +0.15 (+1.84%)

After market: 8.4 +0.1 (+1.2%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.774B
14.03%
1.118B
-36.99%
1.049B
-6.10%
1.119B
6.64%
1.208B
7.95%
1.092B
-9.60%
761.34M
-30.28%
789.62M
3.71%
1B
26.63%
955.46M
-4.44%
EBITDA
YoY % growth
506.9M
-14.75%
-20M
-103.95%
-76.4M
-282.00%
186.65M
344.31%
58.176M
-68.83%
134.43M
131.07%
133.62M
-0.60%
132.31M
-0.98%
N/AN/A
EBIT
YoY % growth
383.1M
-20.20%
-163.3M
-142.63%
-201.5M
-23.39%
-34.643M
82.81%
-70.7M
-104.08%
-95.95M
-35.71%
12.625M
113.16%
11.211M
-11.20%
N/AN/A
Operating Margin
21.60%-14.61%-19.20%-3.10%-5.85%-8.79%1.66%1.42%N/AN/A
EPS
YoY % growth
6.00
-23.57%
-2.26
-137.67%
-5.48
-142.48%
-1.01
81.57%
3.02
399.00%
2.20
-27.09%
-0.04
-101.83%
-0.04N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.65
16.05%
Revenue
Q2Q % growth
261.59M
-5.43%
EBITDA
Q2Q % growth
22.927M
-71.80%
EBIT
Q2Q % growth
38.077M
186.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.37
385.42%
0.141.23868.88%
Q2 2024
Q2Q % growth
-2.32
-118.87%
-0.95-1.37-143.07%
Q1 2024
Q2Q % growth
0.59
118.61%
-0.871.46167.93%
Q4 2023
Q2Q % growth
-0.77
-148.39%
-0.19-0.58-301.25%
Q3 2023
Q2Q % growth
-0.48
62.20%
-0.23-0.25-112.80%
Q2 2023
Q2Q % growth
-1.06
-23.26%
-0.49-0.57-115.65%
Q1 2023
Q2Q % growth
-3.17
-1,861.11%
-1.25-1.92-153.11%
Q4 2022
Q2Q % growth
-0.31
-106.89%
0.04-0.35-797.57%
Q3 2022
Q2Q % growth
-1.27
-252.78%
-0.06-1.21-1,938.96%
Q2 2022
Q2Q % growth
-0.86
-360.61%
0.38-1.24-327.06%
Q1 2022
Q2Q % growth
0.18
-88.24%
0.130.0542.57%
Q4 2021
Q2Q % growth
4.50
22.62%
4.310.194.38%
Q3 2021
Q2Q % growth
-0.36
-116.44%
2.37-2.73-115.18%
Q2 2021
Q2Q % growth
0.33
-83.33%
1.56-1.23-78.83%
Q1 2021
Q2Q % growth
1.53
15,200.00%
1.130.4034.91%
Q4 2020
Q2Q % growth
3.67
133.76%
3.220.4514.01%
Q3 2020
Q2Q % growth
2.19
80.99%
2.140.052.35%
Q2 2020
Q2Q % growth
1.98
1,550.00%
0.691.29186.89%
Q1 2020
Q2Q % growth
0.01
107.69%
0.010.00-0.99%
Q4 2019
Q2Q % growth
1.57
109.33%
1.75-0.18-10.37%
Q3 2019
Q2Q % growth
1.21
120.00%
0.910.3033.69%
Q2 2019
Q2Q % growth
0.12
-88.79%
0.17-0.05-28.91%
Q1 2019
Q2Q % growth
-0.13
-333.33%
0.10-0.23-236.51%
Q4 2018
Q2Q % growth
0.75 0.660.0913.80%
Q3 2018
Q2Q % growth
0.55 0.59-0.04-6.80%
Q2 2018
Q2Q % growth
1.07 0.890.1820.39%
Q1 2018
Q2Q % growth
-0.03 0.22-0.25-113.40%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
293.8M
8.61%
300.48M-6.68M-2.22%
Q2 2024
Q2Q % growth
254.7M
-24.62%
191.9M62.8M32.73%
Q1 2024
Q2Q % growth
300.4M
81.95%
222.45M77.95M35.04%
Q4 2023
Q2Q % growth
276.6M
-16.36%
296.47M-19.87M-6.70%
Q3 2023
Q2Q % growth
270.5M
12.71%
239.81M30.69M12.80%
Q2 2023
Q2Q % growth
337.9M
39.23%
218.33M119.57M54.77%
Q1 2023
Q2Q % growth
165.1M
-46.31%
144.71M20.39M14.09%
Q4 2022
Q2Q % growth
330.7M
-54.27%
299.59M31.11M10.38%
Q3 2022
Q2Q % growth
240M
-27.05%
270.98M-30.98M-11.43%
Q2 2022
Q2Q % growth
242.7M
-38.94%
273.65M-30.95M-11.31%
Q1 2022
Q2Q % growth
307.5M
-10.35%
286.41M21.09M7.36%
Q4 2021
Q2Q % growth
723.2M
24.05%
698.27M24.93M3.57%
Q3 2021
Q2Q % growth
329M
-14.59%
491.71M-162.71M-33.09%
Q2 2021
Q2Q % growth
397.5M
0.71%
402.92M-5.42M-1.35%
Q1 2021
Q2Q % growth
343M
78.18%
362.06M-19.06M-5.26%
Q4 2020
Q2Q % growth
583M
61.81%
569.58M13.42M2.36%
Q3 2020
Q2Q % growth
385.2M
23.54%
442.31M-57.11M-12.91%
Q2 2020
Q2Q % growth
394.7M
62.29%
297.68M97.02M32.59%
Q1 2020
Q2Q % growth
192.5M
1.00%
200.89M-8.39M-4.18%
Q4 2019
Q2Q % growth
360.3M
33.10%
360.99M-690K-0.19%
Q3 2019
Q2Q % growth
311.8M
79.50%
292.16M19.64M6.72%
Q2 2019
Q2Q % growth
243.2M
10.45%
214.18M29.02M13.55%
Q1 2019
Q2Q % growth
190.6M
61.80%
203.18M-12.58M-6.19%
Q4 2018
Q2Q % growth
270.7M 273.36M-2.66M-0.97%
Q3 2018
Q2Q % growth
173.7M 185.94M-12.24M-6.58%
Q2 2018
Q2Q % growth
220.2M 210.65M9.55M4.53%
Q1 2018
Q2Q % growth
117.8M 141.82M-24.02M-16.94%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -161.22% 13.04% 50.98%
Revenue0% -4.83% -1.24% -0.18%